by In2Pharma | Apr 4, 2025 | News
The Netherlands Keuringsraad KOAGKAG can be consulted for advice with regard to promotional material and claims taking into account the current codes and guidelines for medicinal products, medical devices and health products. As the complexity of the questions...
by In2Pharma | Apr 4, 2025 | News
The Netherlands GMH has published an updated version of the GMH code. For example, the new maximum rates for service fees for this year, 2025, have been implemented. There were no alterations content-wise, but more explanation has been added on different points....
by In2Pharma | Jan 7, 2025 | News
The Netherlands Starting January 1, 2025, several changes to the KOAG KAG rates and procedure have taken effect. Updates rates To align the rates with the workload associated with each type of material, the pricing structure has been re-evaluated. Most rates remain...
by In2Pharma | Dec 27, 2024 | News
The Netherlands Patients with severe conditions who have no access to approved medicinal products can receive treatment through a Compassionate Use Program (CUP). The Medicines Evaluation Board (MEB) has published new policy guidelines for the implementation of these...
by In2Pharma | Oct 17, 2024 | News
The Netherlands From 1 October 2024, recall notices and DHPCs will be distributed by e-mail as much as possible. In the past, marketing authorisation holders send these risk communications by post to healthcare professionals in special “Orange Hand” envelopes (for...
